The angiotensin converting enzyme 2 (ACE2) system in the brain: possible involvement in Neuro-Covid
- PMID: 34142714
- DOI: 10.14670/HH-18-356
The angiotensin converting enzyme 2 (ACE2) system in the brain: possible involvement in Neuro-Covid
Abstract
The brain has its own intrinsic renin-angiotensin system (RAS) with all its components present in the central nervous system (CNS). Recent data demonstrate that also the main components of the angiotensin concerting enzyme 2 (ACE2) system (at least ACE2 itself, as well as the biologically active angiotensin (1-7) and its cognate receptor Mas) are expressed in the brain. Aside from these members, alamadine and MrgD are discussed as further members that have neuro-active roles in the CNS. Little is known about the possible functions of MrgD within the brain. Concerning angiotensin (1-7) acting through the Mas receptor, data were accumulating that this system is involved in numerous processes contributing to neuronal plasticity and even learning and memory. Malfunctions in the brain ACE2 system are associated with disturbances in neuronal plasticity. Since SARS-CoV-2 has a high affinity towards ACE2, Neuro-Covid may directly or indirectly depend on a disturbed balance in the ACE2 derived angiotensin system in the brain. Since the ACE2 system in the brain is far from being understood, a deeper understanding of e.g. the angiotensin (1-7) / Mas system is needed, especially with regard to the roles of angiotensin (1-7) in neuronal plasticity.
References
-
- Agrawal M., Saraf S., Saraf S., Antimisiaris S.G., Chougule M.B., Shoyele S.A. and Alexander A. (2018). Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs. J. Control Release 281, 139-177. - PubMed
-
- Almeida-Santos A.F., de Melo L.A., Goncalves S.C.A., Oliveira Amaral L.B., Santos R.A.S., Campagnole-Santos M.J. and Kangussu L.M. (2021). Alamandine through mrgd receptor induces antidepressantlike effect in transgenic rats with low brain angiotensinogen. Horm. Behav. 127, 104880 - PubMed
-
- Arisoy S., Sayiner O., Comoglu T., Onal D., Atalay O. and Pehlivanoglu B. (2020). In vitro and in vivo evaluation of levodopa-loaded nanoparticles for nose to brain delivery. Pharm. Dev. Technol. 25, 735-747. - PubMed
-
- Bader M., Alenina N., Andrade-Navarro M.A. and Santos R.A. (2014). Mas and its related g protein-coupled receptors, mrgprs. Pharmacol. Rev. 66, 1080-1105. - PubMed
-
- Bennion D.M., Jones C.H., Dang A.N., Isenberg J., Graham J.T., Lindblad L., Domenig O., Waters M.F., Poglitsch M., Sumners C. and Steckelings U.M. (2018). Protective effects of the angiotensin II AT2 receptor agonist compound 21 in ischemic stroke: A nose-tobrain delivery approach. Clin. Sci. (Lond.) 132, 581-593. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous